CompletedPhase 2NCT03772314

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

Studying Idiopathic hypersomnia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
Lynn Marie Trotti, MD, MSc
Emory University
Intervention
Modafinil(drug)
Enrollment
44 enrolled
Eligibility
18-65 years · All sexes
Timeline
2019 – 2023

Study locations (1)

Collaborators

American Academy of Sleep Medicine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03772314 on ClinicalTrials.gov

Other trials for Idiopathic hypersomnia

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic hypersomnia →

← Back to all trials